Canada markets closed

Silence Therapeutics plc (SLN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
21.99+0.69 (+3.24%)
At close: 04:00PM EDT
21.99 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.12B
Enterprise Value 1.05B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)25.64
Price/Book (mrq)47.95
Enterprise Value/Revenue 41.43
Enterprise Value/EBITDA -21.12

Trading Information

Stock Price History

Beta (5Y Monthly) 1.40
52-Week Change 3230.23%
S&P500 52-Week Change 322.38%
52 Week High 327.72
52 Week Low 34.84
50-Day Moving Average 322.90
200-Day Moving Average 314.77

Share Statistics

Avg Vol (3 month) 3231.56k
Avg Vol (10 day) 3176.02k
Shares Outstanding 546.62M
Implied Shares Outstanding 636.75M
Float 872.94M
% Held by Insiders 117.00%
% Held by Institutions 147.57%
Shares Short (Apr 15, 2024) 4162.01k
Short Ratio (Apr 15, 2024) 40.93
Short % of Float (Apr 15, 2024) 4N/A
Short % of Shares Outstanding (Apr 15, 2024) 40.31%
Shares Short (prior month Mar 15, 2024) 492.66k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -170.51%
Operating Margin (ttm)-633.59%

Management Effectiveness

Return on Assets (ttm)-30.80%
Return on Equity (ttm)-221.19%

Income Statement

Revenue (ttm)25.38M
Revenue Per Share (ttm)0.68
Quarterly Revenue Growth (yoy)-56.00%
Gross Profit (ttm)N/A
EBITDA -49.27M
Net Income Avi to Common (ttm)-43.27M
Diluted EPS (ttm)-1.46
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)54.03M
Total Cash Per Share (mrq)0.39
Total Debt (mrq)272k
Total Debt/Equity (mrq)1.59%
Current Ratio (mrq)4.56
Book Value Per Share (mrq)0.43

Cash Flow Statement

Operating Cash Flow (ttm)-39.35M
Levered Free Cash Flow (ttm)-22.88M